[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Factor VIII Market Report 2016

September 2016 | 124 pages | ID: U68E429192FEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Factor VIII

Revenue, means the sales value of Factor VIII

This report studies sales (consumption) of Factor VIII in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • CSL Ltd. (Australia)
  • Grifols S.A (Spain)
  • Baxalta Incorporated (U.S.)
  • Octapharma AG (Switzerland)
  • Kedrion S.p.A (Italy)
  • China Biologic Products, Inc. (China)
  • Biotest AG (Germany)
  • LFB S.A (France)
  • Bio Product Laboratory Ltd. (U.K.)
  • Sanquin (Netherlands)
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by applications, this report focuses on sales, market share and growth rate of Factor VIII in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
United States Factor VIII Market Report 2016

1 FACTOR VIII OVERVIEW

1.1 Product Overview and Scope of Factor VIII
1.2 Classification of Factor VIII
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Factor VIII
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Factor VIII (2011-2021)
  1.4.1 USA Factor VIII Sales and Growth Rate (2011-2021)
  1.4.2 USA Factor VIII Revenue and Growth Rate (2011-2021)

2 USA FACTOR VIII COMPETITION BY MANUFACTURERS

2.1 USA Factor VIII Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Factor VIII Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Factor VIII Average Price by Manufactures (2015 and 2016)
2.4 Factor VIII Market Competitive Situation and Trends
  2.4.1 Factor VIII Market Concentration Rate
  2.4.2 Factor VIII Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 USA FACTOR VIII SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 USA Factor VIII Sales and Market Share by Type (2011-2016)
3.2 USA Factor VIII Revenue and Market Share by Type (2011-2016)
3.3 USA Factor VIII Price by Type (2011-2016)
3.4 USA Factor VIII Sales Growth Rate by Type (2011-2016)

4 USA FACTOR VIII SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 USA Factor VIII Sales and Market Share by Application (2011-2016)
4.2 USA Factor VIII Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 USA FACTOR VIII MANUFACTURERS PROFILES/ANALYSIS

5.1 CSL Ltd. (Australia)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Factor VIII Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 CSL Ltd. (Australia) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Grifols S.A (Spain)
  5.2.2 Factor VIII Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Grifols S.A (Spain) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Baxalta Incorporated (U.S.)
  5.3.2 Factor VIII Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Baxalta Incorporated (U.S.) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Octapharma AG (Switzerland)
  5.4.2 Factor VIII Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Octapharma AG (Switzerland) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Kedrion S.p.A (Italy)
  5.5.2 Factor VIII Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Kedrion S.p.A (Italy) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 China Biologic Products, Inc. (China)
  5.6.2 Factor VIII Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 China Biologic Products, Inc. (China) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Biotest AG (Germany)
  5.7.2 Factor VIII Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Biotest AG (Germany) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 LFB S.A (France)
  5.8.2 Factor VIII Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 LFB S.A (France) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Bio Product Laboratory Ltd. (U.K.)
  5.9.2 Factor VIII Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Bio Product Laboratory Ltd. (U.K.) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Sanquin (Netherlands)
  5.10.2 Factor VIII Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Sanquin (Netherlands) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 FACTOR VIII MANUFACTURING COST ANALYSIS

6.1 Factor VIII Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Factor VIII

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Factor VIII Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Factor VIII Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 USA FACTOR VIII MARKET FORECAST (2016-2021)

10.1 USA Factor VIII Sales, Revenue Forecast (2016-2021)
10.2 USA Factor VIII Sales Forecast by Type (2016-2021)
10.3 USA Factor VIII Sales Forecast by Application (2016-2021)
10.4 Factor VIII Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Factor VIII
Table Classification of Factor VIII
Figure USA Sales Market Share of Factor VIII by Type in 2015
Table Application of Factor VIII
Figure USA Sales Market Share of Factor VIII by Application in 2015
Figure USA Factor VIII Sales and Growth Rate (2011-2021)
Figure USA Factor VIII Revenue and Growth Rate (2011-2021)
Table USA Factor VIII Sales of Key Manufacturers (2015 and 2016)
Table USA Factor VIII Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Factor VIII Sales Share by Manufacturers
Figure 2016 Factor VIII Sales Share by Manufacturers
Table USA Factor VIII Revenue by Manufacturers (2015 and 2016)
Table USA Factor VIII Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Factor VIII Revenue Share by Manufacturers
Table 2016 USA Factor VIII Revenue Share by Manufacturers
Table USA Market Factor VIII Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Factor VIII Average Price of Key Manufacturers in 2015
Figure Factor VIII Market Share of Top 3 Manufacturers
Figure Factor VIII Market Share of Top 5 Manufacturers
Table USA Factor VIII Sales by Type (2011-2016)
Table USA Factor VIII Sales Share by Type (2011-2016)
Figure USA Factor VIII Sales Market Share by Type in 2015
Table USA Factor VIII Revenue and Market Share by Type (2011-2016)
Table USA Factor VIII Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Factor VIII by Type (2011-2016)
Table USA Factor VIII Price by Type (2011-2016)
Figure USA Factor VIII Sales Growth Rate by Type (2011-2016)
Table USA Factor VIII Sales by Application (2011-2016)
Table USA Factor VIII Sales Market Share by Application (2011-2016)
Figure USA Factor VIII Sales Market Share by Application in 2015
Table USA Factor VIII Sales Growth Rate by Application (2011-2016)
Figure USA Factor VIII Sales Growth Rate by Application (2011-2016)
Table CSL Ltd. (Australia) Basic Information List
Table CSL Ltd. (Australia) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Figure CSL Ltd. (Australia) Factor VIII Sales Market Share (2011-2016)
Table Grifols S.A (Spain) Basic Information List
Table Grifols S.A (Spain) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Grifols S.A (Spain) Factor VIII Sales Market Share (2011-2016)
Table Baxalta Incorporated (U.S.) Basic Information List
Table Baxalta Incorporated (U.S.) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Baxalta Incorporated (U.S.) Factor VIII Sales Market Share (2011-2016)
Table Octapharma AG (Switzerland) Basic Information List
Table Octapharma AG (Switzerland) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Octapharma AG (Switzerland) Factor VIII Sales Market Share (2011-2016)
Table Kedrion S.p.A (Italy) Basic Information List
Table Kedrion S.p.A (Italy) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kedrion S.p.A (Italy) Factor VIII Sales Market Share (2011-2016)
Table China Biologic Products, Inc. (China) Basic Information List
Table China Biologic Products, Inc. (China) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table China Biologic Products, Inc. (China) Factor VIII Sales Market Share (2011-2016)
Table Biotest AG (Germany) Basic Information List
Table Biotest AG (Germany) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biotest AG (Germany) Factor VIII Sales Market Share (2011-2016)
Table LFB S.A (France) Basic Information List
Table LFB S.A (France) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table LFB S.A (France) Factor VIII Sales Market Share (2011-2016)
Table Bio Product Laboratory Ltd. (U.K.) Basic Information List
Table Bio Product Laboratory Ltd. (U.K.) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bio Product Laboratory Ltd. (U.K.) Factor VIII Sales Market Share (2011-2016)
Table Sanquin (Netherlands) Basic Information List
Table Sanquin (Netherlands) Factor VIII Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanquin (Netherlands) Factor VIII Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Factor VIII
Figure Manufacturing Process Analysis of Factor VIII
Figure Factor VIII Industrial Chain Analysis
Table Raw Materials Sources of Factor VIII Major Manufacturers in 2015
Table Major Buyers of Factor VIII
Table Distributors/Traders List
Figure USA Factor VIII Production and Growth Rate Forecast (2016-2021)
Figure USA Factor VIII Revenue and Growth Rate Forecast (2016-2021)
Table USA Factor VIII Production Forecast by Type (2016-2021)
Table USA Factor VIII Consumption Forecast by Application (2016-2021)


More Publications